News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
140 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Pharm Country
Global Pharmaceutical Glass Packaging Market to Witness a CAGR of 7.5% during 2018-2024
Global pharmaceutical glass packaging market was valued at USD 13,468 million in 2017 and is expected to reach USD 22,169 million by 2024, at a CAGR of 7.5%.
July 11, 2018
·
4 min read
Drug Development
Janssen Provides Update on IMBRUVICA® (ibrutinib) Phase 3 PHOENIX Trial in Newly Diagnosed Non-Germinal Center B Cell (Non-GCB) Subtype of Diffuse Large B-Cell Lymphoma (DLBCL)
The clinical trial did not meet the primary endpoint of event-free survival in patients with non-GCB subtype of DLBCL
July 11, 2018
·
12 min read
Business
Dr. Milan Mrksich Joins SLAS Technology’s Scientific Advisory Board
SAMDI Tech Inc. is pleased to announce that Dr. Milan Mrksich, founder of SAMDI Tech and professor at Northwestern University, has been selected to serve as a scientific advisor for SLAS Technology.
July 11, 2018
·
1 min read
Business
ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers
ResMed today announced their agreement to form a new joint venture.
July 11, 2018
·
3 min read
Policy
22nd Century Reports on New Responses to the FDA’s Nicotine Reduction Plan
Scientists highlight reduced consumption; refute claims of compensation; support an immediate reduction in nicotine level
July 11, 2018
·
5 min read
Lone Star Bio
KCI Expands Offering of Next Generation Negative Pressure Wound Therapy Dressing
V.A.C. VERAFLO CLEANSE CHOICE™ Large Dressing allows for expanded use of dressing on larger complex wounds
July 11, 2018
·
4 min read
Business
New Company Sets Sights On Treating Concussions
Neurologics applies proprietary technology to remediate and improve brain function for traumatic brain injuries.
July 11, 2018
·
3 min read
Genetown
Orig3n Expands Globally with Funding from Haitong International, International Tech Conference Partnerships
Collaborations will support continued growth of research and development efforts
July 11, 2018
·
3 min read
Drug Development
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome
Aurinia Pharmaceuticals Inc. announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).
July 11, 2018
·
4 min read
Business
AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
AcelRx Pharmaceuticals, Inc. announced that it has commenced an underwritten public offering of shares of its common stock.
July 11, 2018
·
3 min read
Previous
8 of 14
Next